SEC Form 4 · accession 0001041889-15-000028
PSYCHEMEDICS CORP · PMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Neil Lerner
Officer — VP - Finance
Period of report
Sep 15, 2015
Accepted (ET)
Sep 17, 2015 · 4:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000806517
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $10.21 | Sep 15, 2015 | A | 2,000 | A | — | Sep 15, 2025 | Common Stock, $.005 Par Value | 2,000 | 2,000 | D |
Explanation of responses
- F1The option becomes exercisable with respect to 20% of the shares on the first anniversary date of grant, and with respect to an additional 20% on each of the four anniversary dates thereafter.